EXCLUSIVE: Avalon GloboCare Inks MoU With Qi Diagnostics For Proposed Co-Development Of Real-Time Cannabis Breathalyzer

EXCLUSIVE: Avalon GloboCare Inks MoU With Qi Diagnostics For Proposed Co-Development Of Real-Time Cannabis Breathalyzer

Avalon GloboCare Corp. signed an MOU with Qi Diagnostics to explore a partnership in developing a nanosensor-based cannabis breathalyzer. The agreement grants Avalon a 120-day exclusivity period to negotiate a definitive collaboration.

Read More

Did you find this insightful?